Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 04, 2026
ONEOK (OKE) Delivers Q2 2026 Beat and Raises Guidance, Shares Fall -3%

ONEOK (OKE) Delivers Q2 2026 Beat and Raises Guidance, Shares Fall -3%

Key Takeaways

  • ONEOK reported second-quarter 2026 net income attributable to ONEOK of $966 million, or $1.53 per diluted share, beating analyst consensus estimates of approximately $1.46 to $1.49 per share.
  • Revenue climbed 52.8% year-over-year to $12.05 billion, well above the FactSet consensus estimate of $8.95 billion.
  • Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 7% to $2.12 billion, supported by record NGL (natural gas liquids) raw feed throughput volumes.
  • ONEOK raised its full-year 2026 financial guidance, lifting the EPS (earnings per share) midpoint to $5.68 and adjusted EBITDA midpoint to $8.35 billion.
  • Despite the earnings beat and guidance increase, ONEOK shares fell approximately 3% in the trading session following the release.

Why ONEOK’s Q2 Results Carry Weight

ONEOK’s second-quarter 2026 earnings carried added importance after a mixed first quarter that included an EPS miss. As one of North America’s largest midstream operators, OKE sits at the center of rising natural gas demand from data centers and LNG exports, shifting production dynamics between the Permian and Bakken, and the ongoing integration of the EnLink and Medallion acquisitions. With roughly 90% of earnings tied to fee-based contracts, the results offer a useful read on broader midstream health and volume trends.

The Quarter’s Reported Numbers

ONEOK posted second-quarter 2026 net income of $967 million, of which $966 million was attributable to shareholders—a 13% increase from $853 million ($841 million attributable) a year earlier. Diluted EPS reached $1.53, up from $1.34 and above the consensus range of $1.46 to $1.49. Revenue jumped 52.8% to $12.05 billion from $7.89 billion, clearing the FactSet estimate of $8.95 billion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Adjusted EBITDA climbed 7% to $2.12 billion from $1.98 billion, helped by record NGL raw feed throughput and higher natural gas processing and refined products volumes. Operating income rose to $1.59 billion from $1.43 billion. Key volume moves included an 8% rise in refined products shipped, a 7% increase in NGL raw feed throughput (with a 15% jump in the Gulf Coast/Permian area), and a 2% gain in natural gas volumes processed. The Greater Denver refined products pipeline expansion reached mechanical completion in early August.

Market Reaction and Sentiment

Even with the earnings and revenue beats, OKE shares declined about 3% on the announcement day, closing near $88. The move likely reflected a few factors. The full-year 2026 EPS guidance midpoint of $5.68 came in just below the $5.79 consensus, which may have tempered expectations for a larger raise. Concerns about volume growth sustainability in the Bakken and Morgan Stanley’s recent downgrade to Equal Weight also weighed on sentiment. The reaction followed a similar pattern after the first-quarter report earlier in the year.

Guidance and Factors to Watch

ONEOK lifted its 2026 outlook, now projecting net income between $3.41 billion and $3.79 billion, adjusted EBITDA of $8.2 billion to $8.5 billion, and EPS at a $5.68 midpoint. Capital expenditure guidance stays at $2.7 billion to $3.2 billion. The mechanical completion of the Greater Denver pipeline should support incremental volumes ahead. Permian processing growth is expected to continue, helping offset steadier activity in the Bakken. Investors will also track commodity price spreads, the pace of EnLink and Medallion integration synergies, and macro drivers such as data-center gas demand and LNG exports that support the fee-based model.

Using Tickeron’s AI Screener in My Workflow

When I review earnings like these, Tickeron’s AI Screener helps me quickly filter midstream names against peers on volume trends, valuation, and technical signals. It surfaces comparable ideas efficiently and adds useful context to the reported results without replacing the core fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: OKE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


OKE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for OKE turned positive on August 11, 2026. Looking at past instances where OKE's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 10, 2026. You may want to consider a long position or call options on OKE as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

OKE moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OKE crossed bullishly above the 50-day moving average on July 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OKE advanced for three days, in of 379 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 259 cases where OKE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OKE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.541) is normal, around the industry mean (185.773). P/E Ratio (15.971) is within average values for comparable stocks, (24.182). Projected Growth (PEG Ratio) (2.017) is also within normal values, averaging (3.998). Dividend Yield (0.046) settles around the average of (0.049) among similar stocks. P/S Ratio (1.484) is also within normal values, averaging (4.571).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OKE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 43, placing this stock slightly worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Enterprise Products Partners LP (NYSE:EPD), Energy Transfer LP (NYSE:ET), Kinder Morgan (NYSE:KMI), Targa Resources Corp (NYSE:TRGP), Cheniere Energy (NYSE:LNG), Plains All American Pipeline LP (NASDAQ:PAA), Antero Midstream Corp (NYSE:AM), Plains GP Holdings LP (NASDAQ:PAGP), CMB.TECH NV (NYSE:CMBT), Scorpio Tankers (NYSE:STNG).

Industry description

Oil & Gas Pipelines industry includes companies that transport natural gas and crude oil through pipelines. These companies also collect and market the fuels. The pipeline segment could be considered as a midstream operation – functioning as a link between the upstream and downstream operations in the oil and gas industry. Some of the largest U.S. pipeline players include Enterprise Products Partners L.P, TC Energy Corporation and Energy Transfer, L.P.

Market Cap

The average market capitalization across the Oil & Gas Pipelines Industry is 16.79B. The market cap for tickers in the group ranges from 7.66K to 112.44B. ENB holds the highest valuation in this group at 112.44B. The lowest valued company is AVACF at 7.66K.

High and low price notable news

The average weekly price growth across all stocks in the Oil & Gas Pipelines Industry was 4%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 15%. BANL experienced the highest price growth at 55%, while EE experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Oil & Gas Pipelines Industry was -24%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 25
P/E Growth Rating: 51
Price Growth Rating: 49
SMR Rating: 61
Profit Risk Rating: 43
Seasonality Score: -12 (-100 ... +100)
View a ticker or compare two or three
OKE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which purchases, gathers, compresses, transports and stores natural gas

Industry OilGasPipelines

Profile
Details
Industry
Oil And Gas Pipelines
Address
100 West Fifth Street
Phone
+1 918 588-7000
Employees
4775
Web
https://www.oneok.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.